Marine-Derived Polymers–Polysaccharides as Promising Natural Therapeutics for Atherosclerotic Cardiovascular Disease
Marine Drugs · 12.08.2025 · 23 (8) · 325
DOI: 10.3390/md23080325 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Marine Drugs, online erschienen am 12.08.2025. Verfasst von Edmond Leonard Jim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Vascular Medicine, Faculty of Medicine, Sam Ratulangi University, Manado 95115, Indonesia. Hauptthemen laut MEDLINE: Polysaccharides, Atherosclerosis, Aquatic Organisms, Biological Products. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of morbidity and mortality worldwide, driven by dyslipidemia, chronic inflammation, oxidative stress, and endothelial dysfunction. Despite widespread use of lipid-lowering and anti-inflammatory agents such as statins, residual cardiovascular risk and adverse effects underscore the need for novel, safe, and multi-targeted therapies. Marine-derived polysaccharides (MDPs)—including fucoidan, alginate, laminarin, carrageenan, and chitosan—exhibit a spectrum of bioactivities relevant to ASCVD pathogenesis, such as anti-inflammatory, antioxidant, lipid-modulatory, antithrombotic, and endothelial-protective effects. In this critical review, we synthesize preclinical and emerging clinical evidence on the pharmacokinetics, mechanisms of action, and therapeutic potential of these compounds. We highlight translational challenges, including structural variability, poor oral bioavailability, and limited human data, and propose strategies to overcome these barriers, such as molecular standardization, novel delivery systems, and well-designed clinical trials. MDPs represent promising natural therapeutics for ASCVD prevention and treatment, warranting further investigation in rigorous human studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology and Vascular Medicine, Faculty of Medicine, Sam Ratulangi University, Manado 95115, Indonesia.
- Department of Internal Medicine, Royal Taruma Hospital, Jakarta 11470, Indonesia.
- Department of Food Technology, Faculty of Engineering, Bina Nusantara University, Jakarta 11480, Indonesia.
- Department of Biochemistry and Biomolecular, Faculty of Medicine, Universitas Brawijaya, Malang 65145, Indonesia.
- Master of Basic Medical Science, Faculty of Medicine, Universitas Airlangga, Surabaya 60131, Indonesia.
- Institute for Research and Community Service, State Islamic University of Sunan Kalijaga (UIN Sunan Kalijaga), Yogyakarta 55281, Indonesia.
ORCID-Profile: Reggie Surya, Happy Kurnia Permatasari, Fahrul Nurkolis
Zitieren
APA
Jim, E. L., Jim, E. L., Surya, R., Permatasari, H. K., & Nurkolis, F. (2025). Marine-Derived Polymers–Polysaccharides as Promising Natural Therapeutics for Atherosclerotic Cardiovascular Disease. Marine Drugs, 23(8), 325. https://doi.org/10.3390/md23080325
Vancouver
Jim EL, Jim EL, Surya R, Permatasari HK, Nurkolis F. Marine-Derived Polymers–Polysaccharides as Promising Natural Therapeutics for Atherosclerotic Cardiovascular Disease. Marine Drugs. 2025;23(8):325. doi:10.3390/md23080325
BibTeX
@article{Jim2025,
author = {Jim, Edmond Leonard and Jim, Edwin Leopold and Surya, Reggie and Permatasari, Happy Kurnia and Nurkolis, Fahrul},
title = {Marine-Derived Polymers–Polysaccharides as Promising Natural Therapeutics for Atherosclerotic Cardiovascular Disease},
journal = {Marine Drugs},
year = {2025},
volume = {23},
number = {8},
pages = {325},
doi = {10.3390/md23080325}
}
EUVIMED